Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 8, 2026 · Item 5.07 · Investor press release · Financial statements
Jaguar Health, Inc.
8
Item 5.07
Jun 8, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 5.07 · Investor press release · Financial statements |
| Primary topic | Item 5.07 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Jaguar Health, Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. 1 Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders Lisa Conte, Jaguar’s founder, president & CEO, presenting virtually on June 10, 2026 at the Emerging Growth Conference; click here to register San Francisco, CA (June 8, 2026): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) today announced the voting resu… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 8, 2026 |
| Accession number | 0001193125-26-261910 |
| Reported items | Item 5.07, Regulation FD disclosure (investor press release or presentation), Financial statements and exhibits See Analysis tab for workforce implications |
